Abstract Title:

In vitro and in silico inhibition properties of fucoidan againstα-amylase and α-D-glucosidase with relevance to type 2 diabetes mellitus.

Abstract Source:

Carbohydr Polym. 2019 Apr 1 ;209:350-355. Epub 2019 Jan 14. PMID: 30732817

Abstract Author(s):

Lakshmana Senthil S, Chandrasekaran Raghu, Arjun H A, Anantharaman P

Article Affiliation:

Lakshmana Senthil S


This study investigated the in vitro and in silico inhibitory properties of fucoidan extracted from Turbinaria conoides againstα-amylase and α-D-glucosidase. Extracted fucoidan contained 59 and 35% of fucose and sulphate and was characterized usingH NMR. Dose dependent inhibition assays showed maximum of 85 and 72% of inhibition forα-amylase and α-D-glucosidase at 2.07 and 1.03 μM concentration of fucoidan. The ICvalue of fucoidan was found to be 1.07 and 0.68 μM against α-amylase and α-D-glucosidase. In silico studies (grid based docking) by Schrödinger software revealed that fucoidan as a potent inhibitor for both α-amylase and α-D-glucosidase based on number of interactions, hydrogen bond length and binding energy. Furthermore, fucoidan fulfilled the pharmacokinetic properties thus promising to develop fucoidan as drug for type 2 DM.

Study Type : In Vitro Study

Print Options

Key Research Topics

Sayer Ji
Founder of GreenMedInfo.com

Subscribe to our informative Newsletter & get Nature's Evidence-Based Pharmacy

Our newsletter serves 500,000 with essential news, research & healthy tips, daily.

Download Now

500+ pages of Natural Medicine Alternatives and Information.

This website is for information purposes only. By providing the information contained herein we are not diagnosing, treating, curing, mitigating, or preventing any type of disease or medical condition. Before beginning any type of natural, integrative or conventional treatment regimen, it is advisable to seek the advice of a licensed healthcare professional.

© Copyright 2008-2021 GreenMedInfo.com, Journal Articles copyright of original owners, MeSH copyright NLM.